{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:03:49Z","timestamp":1785387829765,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Anesthesia"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.jclinane.2016.10.025","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T02:10:18Z","timestamp":1480471818000},"page":"84-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Chemotherapy alters cisatracurium induced neuromuscular blockade characteristics: A prospective cohort study"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3911-2256","authenticated-orcid":false,"given":"Amir Poya","family":"Zanjani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maziar","family":"Maghsoudloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalil","family":"Makarem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahimeh","family":"Farokhnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Fazli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid Hussain","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jclinane.2016.10.025_bb0005","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/01.aco.0000169240.14056.19","article-title":"Anaesthesia and anti-cancer chemotherapeutic drugs","volume":"18","author":"Huettemann","year":"2005","journal-title":"Curr Opin Anaesthesiol"},{"issue":"11","key":"10.1016\/j.jclinane.2016.10.025_bb0010","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00003643-200311000-00002","article-title":"Anaesthetic implications of anticancer chemotherapy","volume":"20","author":"Kvolik","year":"2003","journal-title":"Eur J Anaesthesiol"},{"issue":"3","key":"10.1016\/j.jclinane.2016.10.025_bb0015","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1470-2045(05)01768-7","article-title":"Chemotherapy and anaesthetic drugs: too little is known","volume":"6","author":"Zaniboni","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jclinane.2016.10.025_bb0020","series-title":"Anaesthesia and intensive care medicine","first-page":"189","article-title":"Anaesthetic relevance of drugs used to treat cancer","author":"Pleuvry","year":"2006"},{"key":"10.1016\/j.jclinane.2016.10.025_bb0025","series-title":"Current Anaesthesia & Critical Care","first-page":"168","article-title":"Chemotherapy and Anaesthesia","author":"Hegarty","year":"2002"},{"issue":"3","key":"10.1016\/j.jclinane.2016.10.025_bb0030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/ACO.0b013e32814f1c34","article-title":"Anaesthesia for cancer patients","volume":"20","author":"Arain","year":"2007","journal-title":"Curr Opin Anaesthesiol"},{"issue":"6","key":"10.1016\/j.jclinane.2016.10.025_bb0035","first-page":"2023","article-title":"Characterization of the effect of in vivo doxorubicin treatment on skeletal muscle function in the rat","volume":"31","author":"Hydock","year":"2011","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.jclinane.2016.10.025_bb0040","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1213\/00000539-198106000-00011","article-title":"Cancer chemotherapy: implications for the anesthesiologist","volume":"60","author":"Selvin","year":"1981","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jclinane.2016.10.025_bb0045","series-title":"Cancer drug toxicities and Anaesthesia","first-page":"71","author":"Souza","year":"2007"},{"issue":"3","key":"10.1016\/j.jclinane.2016.10.025_bb0050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1445-5994.1972.tb03069.x","article-title":"Cyclophosphamide, cholinesterase and Anaesthesia","volume":"2","author":"Walker","year":"1972","journal-title":"Aust NZ J Med"},{"issue":"2","key":"10.1016\/j.jclinane.2016.10.025_bb0055","first-page":"52","article-title":"Anaesthetic implications of chemotherapy","volume":"12","author":"Allan","year":"2012","journal-title":"contin educ anaesth crit care pain"},{"issue":"1","key":"10.1016\/j.jclinane.2016.10.025_bb0060","first-page":"18","article-title":"Anticancer chemotherapy and it's anaesthetic implications (current concepts)","volume":"53","author":"Gehdoo","year":"2009","journal-title":"Indian J For"},{"issue":"1","key":"10.1016\/j.jclinane.2016.10.025_bb0065","first-page":"8","article-title":"Chemotherapy induced cardiomyopathy: pathogenesis, monitoring and management","volume":"1","author":"Shakir","year":"2009","journal-title":"J Clin Med Res"},{"issue":"2","key":"10.1016\/j.jclinane.2016.10.025_bb0070","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/1097-0142(197902)43:2<465::AID-CNCR2820430210>3.0.CO;2-R","article-title":"Electrocardiographic changes after adriamycin chemotherapy","volume":"43","author":"Ali","year":"1979","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.jclinane.2016.10.025_bb0075","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.pcad.2006.10.002","article-title":"Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management","volume":"49","author":"Takemura","year":"2007","journal-title":"Prog Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.jclinane.2016.10.025_bb0080","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12012-007-0008-2","article-title":"Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis","volume":"7","author":"Wallace","year":"2007","journal-title":"Cardiovasc Toxicol"},{"issue":"3","key":"10.1016\/j.jclinane.2016.10.025_bb0085","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1188\/07.ONF.627-633","article-title":"Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy","volume":"34","author":"Schwartz","year":"2007","journal-title":"Oncol Nurs Forum"},{"issue":"2","key":"10.1016\/j.jclinane.2016.10.025_bb0090","first-page":"355","article-title":"Neurologic complications of cancer drug therapies. CONTINUUM: lifelong learning in neurology","volume":"18","author":"Lee","year":"2012","journal-title":"Neuro-Oncology"},{"issue":"6","key":"10.1016\/j.jclinane.2016.10.025_bb0095","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1152\/japplphysiol.00776.2009","article-title":"Doxorubicin acts through tumor necrosis factor receptor subtype 1 to cause dysfunction of murine skeletal muscle","volume":"107","author":"Gilliam","year":"2009","journal-title":"J Appl Physiol"},{"issue":"1","key":"10.1016\/j.jclinane.2016.10.025_bb0100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/mus.21809","article-title":"Doxorubicin causes diaphragm weakness in murine models of cancer chemotherapy","volume":"43","author":"Gilliam","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jclinane.2016.10.025_bb0105","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1096\/fasebj.22.1_supplement.961.1","article-title":"Doxorubicin stimulates oxidant activity, weakness and fatigue in murine skeletal muscle","volume":"22","author":"Ashley","year":"2008","journal-title":"FASEB J"},{"issue":"5","key":"10.1016\/j.jclinane.2016.10.025_bb0110","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/10428190500402559","article-title":"Cardiopulmonary exercise testing in the evaluation of functional capacity after treatment of lymphomas in adults","volume":"47","author":"Elbl","year":"2006","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.jclinane.2016.10.025_bb0115","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/(SICI)1096-911X(199603)26:3<160::AID-MPO3>3.0.CO;2-I","article-title":"Cardiorespiratory status after treatment for acute lymphoblastic leukemia","volume":"26","author":"Turner-Gomes","year":"1996","journal-title":"Med Pediatr Oncol"},{"issue":"9","key":"10.1016\/j.jclinane.2016.10.025_bb0120","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1089\/ars.2011.3965","article-title":"Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress","volume":"15","author":"Gilliam","year":"2011","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"10.1016\/j.jclinane.2016.10.025_bb0125","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.bjc.6604858","article-title":"Direct effects of doxorubicin on skeletal muscle contribute to fatigue","volume":"100","author":"Van Norren","year":"2009","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.jclinane.2016.10.025_bb0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/cvr\/cvn076","article-title":"Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes","volume":"79","author":"Yamamoto","year":"2008","journal-title":"Cardiovasc Res"},{"issue":"35","key":"10.1016\/j.jclinane.2016.10.025_bb0135","doi-asserted-by":"crossref","first-page":"18750","DOI":"10.1016\/S0021-9258(18)37347-2","article-title":"Mechanism of anthraquinone-induced calcium release from skeletal muscle sarcoplasmic reticulum","volume":"263","author":"Abramson","year":"1988","journal-title":"J Biol Chem"},{"issue":"17","key":"10.1016\/j.jclinane.2016.10.025_bb0140","first-page":"4766","article-title":"Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity","volume":"48","author":"Rajagopalan","year":"1988","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.jclinane.2016.10.025_bb0145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1034\/j.1600-0773.2003.930301.x","article-title":"Doxorubicin-induced cardiac mitochondrionopathy","volume":"93","author":"Wallace","year":"2003","journal-title":"Pharmacol Toxicol"},{"issue":"2","key":"10.1016\/j.jclinane.2016.10.025_bb0150","first-page":"288","article-title":"Ultrastructural features of Adriamycin-induced skeletal and cardiac muscle toxicity","volume":"118","author":"Doroshow","year":"1985","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.jclinane.2016.10.025_bb0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10565-006-0140-y","article-title":"Adriamycin-induced oxidative mitochondrial cardiotoxicity","volume":"23","author":"Berthiaume","year":"2007","journal-title":"Cell Biol Toxicol"},{"issue":"9","key":"10.1016\/j.jclinane.2016.10.025_bb0160","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/0006-2952(88)90437-6","article-title":"Inhibition of flavin metabolism by adriamycin in skeletal muscle","volume":"37","author":"Raiczyk","year":"1988","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.jclinane.2016.10.025_bb0165","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0005-2728(87)90236-2","article-title":"Effects of adriamycin on respiratory chain activities in mitochondria from rat liver, rat heart and bovine heart. Evidence for a preferential inhibition of complex III and IV","volume":"892","author":"Nicolay","year":"1987","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.jclinane.2016.10.025_bb0170","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0009-2797(92)90108-W","article-title":"Mitochondrial oxidation of p-phenylenediamine derivatives in vitro: structure\u2013activity relationships and correlation with myotoxic activity in vivo","volume":"82","author":"Munday","year":"1992","journal-title":"Chem Biol Interact"},{"issue":"4","key":"10.1016\/j.jclinane.2016.10.025_bb0175","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0006-2952(90)90157-G","article-title":"Thiol oxidation and inhibition of Ca-ATPase by adriamycin in rabbit heart microsomes","volume":"39","author":"Vile","year":"1990","journal-title":"Biochem Pharmacol"},{"issue":"17","key":"10.1016\/j.jclinane.2016.10.025_bb0180","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1046\/j.1432-1327.2000.01566.x","article-title":"Ca2+ signalling and muscle disease","volume":"267","author":"MacLennan","year":"2000","journal-title":"Eur J Biochem"},{"issue":"1","key":"10.1016\/j.jclinane.2016.10.025_bb0185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0014-2999(92)90103-B","article-title":"Doxorubicin interacts directly with skinned single skeletal muscle fibres","volume":"214","author":"De Beer","year":"1992","journal-title":"Eur J Pharmacol"}],"container-title":["Journal of Clinical Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952818016309321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952818016309321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T15:02:01Z","timestamp":1779807721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952818016309321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":37,"alternative-id":["S0952818016309321"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinane.2016.10.025","relation":{},"ISSN":["0952-8180"],"issn-type":[{"value":"0952-8180","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemotherapy alters cisatracurium induced neuromuscular blockade characteristics: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinane.2016.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}